Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada
Abstract Background As research on HIV vaccines continues to advance, studies exploring the feasibility of this intervention are necessary to inform uptake and dissemination strategies with key populations, including people who use drugs (PWUD). Methods We conducted 25 in-depth qualitative interview...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | BMC Public Health |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12889-020-09202-6 |
_version_ | 1819015961073680384 |
---|---|
author | Taylor Fleming Jenna Valleriani Cara Ng Lisa Maher Will Small Ryan McNeil |
author_facet | Taylor Fleming Jenna Valleriani Cara Ng Lisa Maher Will Small Ryan McNeil |
author_sort | Taylor Fleming |
collection | DOAJ |
description | Abstract Background As research on HIV vaccines continues to advance, studies exploring the feasibility of this intervention are necessary to inform uptake and dissemination strategies with key populations, including people who use drugs (PWUD). Methods We conducted 25 in-depth qualitative interviews examining HIV vaccine acceptability among PWUD in Vancouver, Canada. Participants were recruited from an ongoing prospective cohort of HIV-negative PWUD. Data were coded using NVivo, and analyzed thematically. Results Acceptability was framed by practical considerations such as cost and side effects, and was influenced by broader trust of government bodies and health care professionals. While an HIV vaccine was perceived as an important prevention tool, willingness to be vaccinated was low. Results suggest that future vaccine implementation must consider how to minimize the burden an HIV vaccine may place on PWUD. Centering the role of health care providers in information dissemination and delivery may assist with uptake. Conclusions Our findings suggest improvements in care and improved patient-provider relationships would increase the acceptability of a potential HIV vaccine among this population. |
first_indexed | 2024-12-21T02:40:03Z |
format | Article |
id | doaj.art-1bf5730b9cb641f69e424047fdff22e9 |
institution | Directory Open Access Journal |
issn | 1471-2458 |
language | English |
last_indexed | 2024-12-21T02:40:03Z |
publishDate | 2020-07-01 |
publisher | BMC |
record_format | Article |
series | BMC Public Health |
spelling | doaj.art-1bf5730b9cb641f69e424047fdff22e92022-12-21T19:18:42ZengBMCBMC Public Health1471-24582020-07-012011910.1186/s12889-020-09202-6Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, CanadaTaylor Fleming0Jenna Valleriani1Cara Ng2Lisa Maher3Will Small4Ryan McNeil5British Columbia Centre on Substance UseBritish Columbia Centre on Substance UseBritish Columbia Centre on Substance UseThe Kirby Institute for Infection and Immunity, Faculty of Medicine, University of New South WalesBritish Columbia Centre on Substance UseBritish Columbia Centre on Substance UseAbstract Background As research on HIV vaccines continues to advance, studies exploring the feasibility of this intervention are necessary to inform uptake and dissemination strategies with key populations, including people who use drugs (PWUD). Methods We conducted 25 in-depth qualitative interviews examining HIV vaccine acceptability among PWUD in Vancouver, Canada. Participants were recruited from an ongoing prospective cohort of HIV-negative PWUD. Data were coded using NVivo, and analyzed thematically. Results Acceptability was framed by practical considerations such as cost and side effects, and was influenced by broader trust of government bodies and health care professionals. While an HIV vaccine was perceived as an important prevention tool, willingness to be vaccinated was low. Results suggest that future vaccine implementation must consider how to minimize the burden an HIV vaccine may place on PWUD. Centering the role of health care providers in information dissemination and delivery may assist with uptake. Conclusions Our findings suggest improvements in care and improved patient-provider relationships would increase the acceptability of a potential HIV vaccine among this population.http://link.springer.com/article/10.1186/s12889-020-09202-6VaccinesHIV/AIDSHIV preventionQualitative research |
spellingShingle | Taylor Fleming Jenna Valleriani Cara Ng Lisa Maher Will Small Ryan McNeil Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada BMC Public Health Vaccines HIV/AIDS HIV prevention Qualitative research |
title | Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada |
title_full | Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada |
title_fullStr | Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada |
title_full_unstemmed | Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada |
title_short | Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada |
title_sort | acceptability of a hypothetical preventative hiv vaccine among people who use drugs in vancouver canada |
topic | Vaccines HIV/AIDS HIV prevention Qualitative research |
url | http://link.springer.com/article/10.1186/s12889-020-09202-6 |
work_keys_str_mv | AT taylorfleming acceptabilityofahypotheticalpreventativehivvaccineamongpeoplewhousedrugsinvancouvercanada AT jennavalleriani acceptabilityofahypotheticalpreventativehivvaccineamongpeoplewhousedrugsinvancouvercanada AT carang acceptabilityofahypotheticalpreventativehivvaccineamongpeoplewhousedrugsinvancouvercanada AT lisamaher acceptabilityofahypotheticalpreventativehivvaccineamongpeoplewhousedrugsinvancouvercanada AT willsmall acceptabilityofahypotheticalpreventativehivvaccineamongpeoplewhousedrugsinvancouvercanada AT ryanmcneil acceptabilityofahypotheticalpreventativehivvaccineamongpeoplewhousedrugsinvancouvercanada |